Patent · US Active

Thrombin/plasmin-regulated antibodies that bind TFPI

US9975962B2 · kind B2 · utility

0Cited by

3References

1Claims

0Family size

Assignee

BAYER HEALTHCARE LLC · DE

Inventors

Zhuozhi Wang · Millbrae, US
Ruth Winter · Oakland, US
John E. Murphy · Mobile, US

Key dates

Filing date	Mar 14, 2013
Grant date	May 22, 2018
Priority date	—
Expiry date	May 7, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/50
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This disclosure provides protease-regulated antibodies which specifically bind to tissue factor pathway inhibitor (TFPI). The antibodies are useful for treating bleeding disorders such as hemophilia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.